| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/30/2011 | US20110160437 Methods of purifying anti a beta antibodies |
| 06/30/2011 | US20110160436 Method to screen high affinity antibody |
| 06/30/2011 | US20110160288 Oip5 as a target gene for cancer therapy and diagnosis |
| 06/30/2011 | US20110160287 Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof |
| 06/30/2011 | US20110160278 Methods For Selectively Modulating Survivin Apoptosis Pathways |
| 06/30/2011 | US20110160126 Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
| 06/30/2011 | US20110159607 Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof |
| 06/30/2011 | US20110159571 Adenovirus targeting |
| 06/30/2011 | US20110159540 Methods for Chemically Synthesizing Immunoglobulin Chimeric Proteins |
| 06/30/2011 | US20110159532 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 06/30/2011 | US20110159526 Methods for prdicting pregnancy outcome in a subject by hcg assay |
| 06/30/2011 | US20110159525 Methods to determine immunogenicity of humanized anti-tag 72 cc49 antibodies |
| 06/30/2011 | US20110159519 Optical biosensors |
| 06/30/2011 | US20110159518 Method for the diagnosis of the presence of an ovarian cancer |
| 06/30/2011 | US20110159514 Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof |
| 06/30/2011 | US20110159041 Chlamydia Trachomatis Genomic Sequence and Polypeptides, Fragments Thereof and Uses Thereof, in Particular for the Diagnosis, Prevention and Treatment of Infection |
| 06/30/2011 | US20110159015 Human antibodies to human angiopoietin-like protein 4 |
| 06/30/2011 | US20110159014 Anti-her2 antibody variants |
| 06/30/2011 | US20110159013 Anti-ADDL Antibodies and Uses Thereof |
| 06/30/2011 | US20110159012 Method for isolating neural cells using tenascin-r compounds |
| 06/30/2011 | US20110159009 Anti-vegf antibodies |
| 06/30/2011 | US20110159008 Antibodies Binding To The Extracellular Domain Of The Receptor Tyrosine Kinase ALK |
| 06/30/2011 | US20110159007 Stable and soluble antibodies inhibiting tnf alpha |
| 06/30/2011 | US20110159006 Use of anti-factor xi antibodies for prevention of thrombus formation |
| 06/30/2011 | US20110159003 Ligands That Bind Il-4 and/or Il-13 |
| 06/30/2011 | US20110159001 CROSS-NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES TO SARS-CoV AND METHODS OF USE THEREOF |
| 06/30/2011 | US20110159000 Antibodies with mannose binding lectin effector function for inhibiting pathologic inflammatory conditions |
| 06/30/2011 | US20110158999 Antagonists of protease activated receptor-1 (par1) |
| 06/30/2011 | US20110158998 Helminth antigen and immunotherapy |
| 06/30/2011 | US20110158997 Single chain fragment variable antibody libraries and uses thereof |
| 06/30/2011 | US20110158995 Multi-Specific Binding Proteins Targeting B Cell Disorders |
| 06/30/2011 | US20110158993 Train-R: A Cysteine Rich Member of the TNF-Receptor Family |
| 06/30/2011 | US20110158992 Engineered Anti-IL-23R Antibodies |
| 06/30/2011 | US20110158991 Cytotoxic agents comprising new maytansinoids |
| 06/30/2011 | US20110158988 Antibodies against extracellular domains 2 and 3 or her2 |
| 06/30/2011 | US20110158986 Humanized antibodies that sequester amyloid beta peptide |
| 06/30/2011 | US20110158984 Anti-orthopoxvirus recombinant polyclonal antibody |
| 06/30/2011 | US20110158982 COMPOSITIONS AND METHODS FOR INHIBITING MAdCAM |
| 06/30/2011 | US20110158981 Methods and Compositions for Inhibiting Binding of IgE to a High Affinity Receptor |
| 06/30/2011 | US20110158977 Immunogenic compositions for Chlamydia trachomatis |
| 06/30/2011 | US20110158906 Targeted block copolymer micelles |
| 06/30/2011 | US20110158905 Dock-and-Lock (DNL) Complexes for Therapeutic and Diagnostic Use |
| 06/30/2011 | US20110158904 Antibodies that bind cell-associated ca 125/o772p and methods of use thereof |
| 06/30/2011 | US20110158902 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 06/30/2011 | US20110155605 Apo-2 ligand |
| 06/30/2011 | CA2785678A1 Human insulin assay and assay reagent |
| 06/30/2011 | CA2785587A1 Binding members for human cytomegalovirus |
| 06/30/2011 | CA2785414A1 Polypeptide modification method for purifying polypeptide multimers |
| 06/30/2011 | CA2785410A1 Tyrosine bioconjugation through aqueous ene-like reactions |
| 06/30/2011 | CA2785178A1 Anti-flt3 antibodies and methods of using the same |
| 06/30/2011 | CA2785158A1 Human antibodies to human angiopoietin-like protein 4 |
| 06/30/2011 | CA2785139A1 Tetravalent cd47-antibody constant region fusion protein for use in therapy |
| 06/30/2011 | CA2784610A1 Immuno-conjugates and methods for producing them 2 |
| 06/30/2011 | CA2784385A1 Anti-bv8 antibodies and uses thereof |
| 06/30/2011 | CA2784345A1 Antibodies to non-functional oligomeric p2x7 receptors |
| 06/30/2011 | CA2782578A1 Sequence dependent aggregation |
| 06/30/2011 | CA2782571A1 Anti-her3 antibodies and uses thereof |
| 06/30/2011 | CA2782300A1 Gene dro1 controlling deep-rooted characteristics of plant and utilization of same |
| 06/30/2011 | CA2777527A1 Method for decreasing immunogenicity |
| 06/29/2011 | EP2339344A1 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 06/29/2011 | EP2339035A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/29/2011 | EP2339027A2 Immunoaffinity isolation of modified peptides from complex mixtures |
| 06/29/2011 | EP2339020A1 Diagnostic methods based on Pregnancy-associated plasma protein-A (PAAP-A) |
| 06/29/2011 | EP2339015A1 Methods for altering protein production rates |
| 06/29/2011 | EP2339004A1 Optimizing glycan processing in plants |
| 06/29/2011 | EP2339002A1 Fibroblast growth factor homologs |
| 06/29/2011 | EP2339000A1 Method for isolation of soluble polypeptides |
| 06/29/2011 | EP2338999A2 Method for isolation of soluble polypeptides |
| 06/29/2011 | EP2338998A1 Method for isolation of soluble polypeptides |
| 06/29/2011 | EP2338986A1 Novel lipases and uses thereof |
| 06/29/2011 | EP2338978A1 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 06/29/2011 | EP2338915A2 Anti-VEGF antibodies |
| 06/29/2011 | EP2338914A1 Connective tissue growth factor antibodies |
| 06/29/2011 | EP2338912A2 Recombinant triplex scaffold-base polypeptides |
| 06/29/2011 | EP2338906A1 Compostion and methods for increasing bone mineralization |
| 06/29/2011 | EP2338902A1 Klebsiella antigens |
| 06/29/2011 | EP2338901A1 Replikin peptides and uses thereof |
| 06/29/2011 | EP2338894A1 Flavivirus fusion inhibitors |
| 06/29/2011 | EP2338516A2 Multiple-variable dose regimen for treating TNF-alpha-related disorders |
| 06/29/2011 | EP2338515A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/29/2011 | EP2338512A1 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 06/29/2011 | EP2338511A2 Prolongation of survival of an allograft by inhibiting complement activity |
| 06/29/2011 | EP2338055A2 Monoclonal antibodies for cspg4 for the diagnosis and treatment of basal breast carcinoma |
| 06/29/2011 | EP2337801A2 Muc1* antibodies |
| 06/29/2011 | EP2337800A1 Antibody combinations and use of same for treating cancer |
| 06/29/2011 | EP2337799A2 Uses of il-22, il-17, and il-1 family cytokines in autoimmune diseases |
| 06/29/2011 | EP2337798A1 Bsa-specific antibodies |
| 06/29/2011 | EP2337796A1 Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation |
| 06/29/2011 | EP2337793A1 Methods of making concentrated fibrinogen- and platelet containing compositions |
| 06/29/2011 | EP2337789A2 Genus-wide chlamydial peptide vaccine antigens |
| 06/29/2011 | EP1981981B1 Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products |
| 06/29/2011 | EP1694850B1 Plasmid system for multigene expression |
| 06/29/2011 | EP1576014B1 Antibodies against pd-1 and uses thereof |
| 06/29/2011 | EP1537147B9 Antibody anti hla-dr with an increased adcc and inducing cytokine production |
| 06/29/2011 | EP1523496B1 Recombinant production of mixtures of antibodies |
| 06/29/2011 | EP1504036B1 Toxin-related fragments of antibodies with antimicrobial and antiviral activity |
| 06/29/2011 | EP1183348B1 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 06/29/2011 | EP1164190B1 Rheumatoid arthritis gene and method for diagnosing rheumatoid arthritis |
| 06/29/2011 | CN1960750B Therapeutic use of anti-CS1 antibodies |
| 06/29/2011 | CN1835769B KIM-1 antagonists and use to modulate immune system |